Browsing byAuthorRawling, T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 55  next >
Issue DateTitleAuthor(s)
2018-06-01Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cordWinters, BL; Rawling, T; Vandenberg, RJ; Christie, MJ; Bhola, RF; Imlach, WL
2016-11-06Alkaloid-like Molecules for Drug DiscoveryWilliams, SG; Rawling, T; Ung, AT
2023-09An update on inflammation in uveal melanoma.Liau, S; Wang, JZ; Zagarella, E; Paulus, P; Dang, NHQH; Rawling, T; Murray, M; Zhou, F
2013-01-01Anti-proliferative actions of N0-desmethylsorafenib in human breast cancer cellsCui, PH; Rawling, T; Gillani, TB; Bourget, K; Wang, XS; Zhou, F; Murray, M
2015-06-01Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugsMurray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T
2017-01-01Antiproliferative activities of alkaloid-like compoundsXu, X; Rawling, T; Roseblade, A; Bishop, R; Ung, AT
2020Antiproliferative activities of tricyclic amides derived from β-caryophyllene via the Ritter reaction against MDA-MB-231 breast cancer cellsXu, X; Roseblade, A; Rawling, T; Ung, AT
2023-07-14Aromatic long chain cations of amphiphilic ionic liquids permeabilise the inner mitochondrial membrane and induce mitochondrial dysfunction at cytotoxic concentrationsDuman, MN; Angeloski, A; Johnson, MS; Rawling, T
-Aryl urea substituted fatty acids: a new class of protonophoric mitochondrial uncoupler that utilises a synthetic anion transporterRawling, T; MacDermott-Opeskin, H; Roseblade, A; Pazderka, C; Clarke, C; Bourget, K; Wu, X; Lewis, W; Noble, B; Gale, PA; O'Mara, ML; Cranfield, C; Murray, M
2019-03-01Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cellsAl-Zubaidi, Y; Pazderka, C; Koolaji, N; Rahman, MK; Choucair, H; Umashankar, B; Bourget, K; Chen, Y; Rawling, T; Murray, M
2018-05-23Carboxylate Analogues of Aryl-Urea-Substituted Fatty Acids That Target the Mitochondria in MDA-MB-231 Breast Cancer Cells to Promote Cell DeathKoolaji, N; Rawling, T; Bourget, K; Murray, M
2013-12-17Cell-derived microparticles: New targets in the therapeutic management of diseaseRoseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M
2008-07-08Convenient synthesis and purification of [Bu<inf>4</inf>N] <inf>2</inf>[Ru(4-carboxy-4-carboxylate-2,2′-bipyridine) <inf>2</inf>(NCS)<inf>2</inf>]: A landmark DSC DyeRawling, T; Buchholz, F; McDonagh, AM
2019-03-14Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 to Produce Analgesia in a Rat Model of Chronic PainMostyn, SN; Rawling, T; Mohammadi, S; Shimmon, S; Frangos, ZJ; Sarker, S; Yousuf, A; Vetter, I; Ryan, RM; Christie, MJ; Vandenberg, RJ
2018-03-01Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liverMurray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T
2021-02-05Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite.Nair, PC; Gillani, TB; Rawling, T; Murray, M
2020-08-16Expansion of the structure-activity relationship of branched chain fatty acids: effect of unsaturation and branching group size on anticancer activity.Roy, R; Roseblade, A; Rawling, T
2010-02-01Facile and stereoselective synthesis of (Z)-15-octadecenoic acid and (Z)-16-nonadecenoic acid: Monounsaturated omega-3 fatty acidsRawling, T; Duke, CC; Cui, PH; Murray, M
2011-05-01Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MSAustin, C; Fryer, F; Lear, J; Bishop, D; Hare, D; Rawling, T; Kirkup, L; McDonagh, A; Doble, P
2023-07-31Fatty Acid-Activated Proton Transport by Bisaryl Anion Transporters Depolarises Mitochondria and Reduces the Viability of MDA-MB-231 Breast Cancer Cells.York, E; McNaughton, DA; Duman, M-N; Gale, PA; Rawling, T